Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

6.60
-0.5100-7.17%
Volume:226.60K
Turnover:1.50M
Market Cap:256.22M
PE:-1.66
High:7.18
Open:7.00
Low:6.44
Close:7.11
52wk High:16.45
52wk Low:5.02
Shares:38.82M
Float Shares:22.72M
Volume Ratio:0.76
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9676
EPS(LYR):-3.4746
ROE:-54.09%
ROA:-29.20%
PB:1.10
PE(LYR):-1.90

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 01, 2025

Correspondence

Form CORRESP - Correspondence
Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities